BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 3140299)

  • 1. Low morbidity following 9,000-rad intracavitary endocurietherapy (ECT) using the Kumar Cervical Applicator and external-beam radiotherapy (EXRT) in the management of carcinoma of the uterine cervix.
    Kumar PP; Good RR; Scott JC; Jones EO; Lynch G; McCaul GF
    Radiat Med; 1988; 6(2):92-106. PubMed ID: 3140299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate and economical intracavitary endocurietherapy in the treatment of uterine cervix cancer.
    Kumar PP; Good RR
    Strahlenther Onkol; 1986 Jan; 162(1):8-12. PubMed ID: 3945922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased morbidity and increased survival in cervical cancer treatment.
    Kumar PP; Good RR; Scott JC; Jones EO
    J Natl Med Assoc; 1988 Oct; 80(10):1113-7. PubMed ID: 3249316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry comparison between interstitial and intracavitary irradiation in the treatment of uterine cervix cancer.
    Kumar PP; Good RR; Jones EO
    Radiat Med; 1986; 4(3):89-96. PubMed ID: 3104997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of afterloading endocurietherapy techniques for vaginal carcinoma.
    Kumar PP; Good RR; Scott JC; Jones EO
    Radiat Med; 1988; 6(2):71-8. PubMed ID: 3140297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAH and BSO with adjuvant pelvic EXRT and vaginal Cs-137 boost in the management of carcinoma of the endometrium.
    Kumar PP; Good RR; Scott JC; McCaul GF
    Radiat Med; 1988; 6(5):240-7. PubMed ID: 3148161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose rate intracavitary therapy for cervical cancer with a microSelectron: a preliminary report.
    Teshima T; Inoue T; Inoue T; Ikeda H; Sasaki S; Yamazaki H; Ohtani M; Murayama S; Kozuka T
    Radiat Med; 1993; 11(6):237-41. PubMed ID: 8153367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
    Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
    Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results.
    Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
    Strahlenther Onkol; 1994 Nov; 170(11):636-42. PubMed ID: 7974179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid-dose rate intracavitary therapy for cervical cancer with a Selectron: a preliminary report.
    Teshima T; Inoue T; Inoue T; Ikeda H; Yamazaki H; Ohtani M; Sasaki S; Murayama S; Kozuka T
    Radiat Med; 1993; 11(6):242-6. PubMed ID: 8153368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
    Khor TH; Tuan JK; Hee SW; Tham IW
    Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
    Dimopoulos JC; Kirisits C; Petric P; Georg P; Lang S; Berger D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):83-90. PubMed ID: 16839702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinoma of the uterine cervix treated with TAO low-dose rate intracavitary radiation].
    Horiuchi J; Shibuya H; Matsumoto S; Suzuki S
    Rinsho Hoshasen; 1989 Nov; 34(12):1483-6. PubMed ID: 2593295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Afterloading intracavitary irradiation therapy for cancer of uterine cervix].
    Lou HK
    Zhonghua Fu Chan Ke Za Zhi; 1993 Nov; 28(11):649-50, 699. PubMed ID: 8313729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [External and intracavitary afterloading radiotherapy of cervical cancer: a report of 110 cases].
    Jiang ZX
    Zhonghua Fu Chan Ke Za Zhi; 1993 Nov; 28(11):651-2, 699-700. PubMed ID: 8313730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of radiation therapy for cancer of the uterine cervix].
    Kodama T; Koga K; Mori N; Fujisaki S; Haruyama Y; Nishikawa K; Jinnouchi S; Nakayama S; Watanabe K
    Gan No Rinsho; 1983 Nov; 29(14):1647-50. PubMed ID: 6663711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.